4//SEC Filing
Kong Garheng 4
Accession 0001867096-22-000097
CIK 0001867096other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 7:05 PM ET
Size
10.1 KB
Accession
0001867096-22-000097
Insider Transaction Report
Form 4
Kong Garheng
Director
Transactions
- Award
Common Stock
2022-06-08+15,000→ 65,170 total - Award
Stock Option (Right to Buy)
2022-06-08+25,000→ 25,000 totalExercise: $2.10From: 2022-06-08Exp: 2032-06-08→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 8, 2023 or the date of the Company's next annual meeting of stockholders.
- [F2]Such options will vest in full upon the earlier to occur of June 8, 2023 or the date of the Company's next annual meeting of stockholders.
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001435183
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 7:05 PM ET
- Size
- 10.1 KB